| RS150288967 |
SLC5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital glucose-galactose malabsorption, Congenital glucose-galactose malabsorption |
| RS150289689 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Hereditary spastic paraplegia |
| RS150290184 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group A, Fanconi anemia |
| RS150290429 |
ADAMTS17
|
Health Risk |
Conflicting classifications of pathogenicity |
Weill-Marchesani 4 syndrome, recessive |
| RS150290493 |
GRM6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150290595 |
CHRNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 2A, Congenital myasthenic syndrome 2A |
| RS150290957 |
SRP54
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150291837 |
C2CD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Jeune thoracic dystrophy |
| RS150292051 |
AQP5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150293706 |
P2RX2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150293825 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome |
| RS150293853 |
MYOT
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 3, Inborn genetic diseases |
| RS150295026 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Cardiovascular phenotype |
| RS150296134 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS150296212 |
PPARG
|
Health Risk |
Likely pathogenic |
PPARG-related familial partial lipodystrophy, INSULIN RESISTANCE |
| RS150296373 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Sotos syndrome |
| RS150298985 |
DOCK8
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to DOCK8 deficiency, Intellectual disability |
| RS150299874 |
L2HGDH
|
Health Risk |
Pathogenic/Likely pathogenic |
L-2-hydroxyglutaric aciduria, L-2-hydroxyglutaric aciduria |
| RS150301281 |
PSEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Acne inversa, familial |
| RS150303433 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Dilated cardiomyopathy 1O |
| RS150303579 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1, Usher syndrome type 1F |
| RS150303834 |
DGAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150303869 |
CP
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of ferroxidase, CP-related disorder |
| RS150303901 |
MCM3AP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150304121 |
YARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, lactic acidosis |
| RS150305320 |
ALDH7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyridoxine-dependent epilepsy, Inborn genetic diseases |
| RS150305490 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, COL4A5-related disorder |
| RS150306354 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Chédiak-Higashi syndrome, Autoinflammatory syndrome |
| RS150306543 |
RECQL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Seizure |
| RS150307169 |
KIF23
|
Health Risk |
Conflicting classifications of pathogenicity |
KIF23-related disorder, KIF23-related disorder |
| RS150308912 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS150309395 |
OSTM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive osteopetrosis 5, Autosomal recessive osteopetrosis 5 |
| RS150309559 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS150309662 |
DCHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150310121 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS150310143 |
MMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Multicentric osteolysis nodulosis arthropathy spectrum, Multicentric osteolysis nodulosis arthropathy spectrum |
| RS150310830 |
GLIS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital aniridia, Neonatal diabetes mellitus with congenital hypothyroidism |
| RS150311153 |
EGF
|
Health Risk |
Conflicting classifications of pathogenicity |
EGF-related disorder, EGF-related disorder |
| RS150311212 |
CFAP418
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Cone-rod dystrophy 16 |
| RS150311870 |
MEGF8
|
Health Risk |
Conflicting classifications of pathogenicity |
MEGF8-related Carpenter syndrome, MEGF8-related Carpenter syndrome |
| RS150312046 |
SCN4B
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 10, Cardiovascular phenotype |
| RS150312425 |
LPIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Majeed syndrome, Autoinflammatory syndrome |
| RS150312765 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS150313058 |
COQ6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150313156 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS150313260 |
UBA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 44 |
| RS150314086 |
CPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital hyperammonemia, type I |
| RS150314171 |
SERPINF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS150314450 |
EIF2AK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Wolcott-Rallison dysplasia |
| RS150314805 |
CEP164
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 15, CEP164-related disorder |
| RS150316347 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Diabetes mellitus, transient neonatal |
| RS150317197 |
IFIH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Singleton-Merten syndrome 1, Aicardi-Goutieres syndrome 7 |
| RS150317593 |
LINS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150317928 |
XIAP
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS150318400 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 11, Cardiomyopathy |
| RS150318692 |
TRIM32
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS150319057 |
LPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperlipoproteinemia, type I |
| RS150319104 |
DKC1
|
Health Risk |
Conflicting classifications of pathogenicity |
History of neurodevelopmental disorder, Dyskeratosis congenita |
| RS150321693 |
AMPD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Erythrocyte AMP deaminase deficiency, Erythrocyte AMP deaminase deficiency |
| RS150321966 |
ECHS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency, Inborn genetic diseases |
| RS150326473 |
KCNJ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Andersen Tawil syndrome, Short QT syndrome type 3 |
| RS150326995 |
HSD17B4
|
Health Risk |
Conflicting classifications of pathogenicity |
Perrault syndrome 1, Bifunctional peroxisomal enzyme deficiency |
| RS150327222 |
SOX10
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150327768 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, Methylcrotonyl-CoA carboxylase deficiency |
| RS150327858 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 5, primary |
| RS150328266 |
FREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 2, Fraser syndrome 2 |
| RS150328574 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS150328847 |
ERCC6L2
|
Health Risk |
Conflicting classifications of pathogenicity |
ERCC6L2-related disorder, Inborn genetic diseases |
| RS150328852 |
KMT2A
|
Health Risk |
Conflicting classifications of pathogenicity |
KMT2A-related disorder, KMT2A-related disorder |
| RS150329686 |
IGSF10
|
Health Risk |
Conflicting classifications of pathogenicity |
IGSF10-related disorder, IGSF10-related disorder |
| RS150331292 |
TRAPPC11
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy |
| RS150331660 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Alstrom syndrome |
| RS150331740 |
PRKCD
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD |
| RS150331976 |
VCAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150332116 |
TMEM67
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS150333718 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS150334315 |
ZBTB11
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal recessive 69 |
| RS150334927 |
CYP27B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitamin D-dependent rickets, type 1 |
| RS150334966 |
NPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C1 |
| RS150335023 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia |
| RS150335311 |
OCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinase-positive oculocutaneous albinism, SKIN/HAIR/EYE PIGMENTATION 1 |
| RS150335599 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS150335679 |
EPHA2
|
Health Risk |
Conflicting classifications of pathogenicity |
EPHA2-related disorder, Colon adenocarcinoma |
| RS150336658 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Autosomal dominant nocturnal frontal lobe epilepsy 1 |
| RS150339335 |
CRB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, CRB2-related disorder |
| RS150339369 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular cardiomyopathy, Cardiovascular phenotype |
| RS150340150 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Autosomal dominant distal renal tubular acidosis |
| RS150340436 |
SCN11A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory and autonomic neuropathy type 7, Familial episodic pain syndrome with predominantly lower limb involvement |
| RS150343359 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS150343794 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Connective tissue disorder |
| RS150343959 |
CLPB
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylglutaconic aciduria, type VIIB |
| RS150344113 |
GHSR
|
Health Risk |
Conflicting classifications of pathogenicity |
Short stature due to growth hormone secretagogue receptor deficiency, GHSR-related disorder |
| RS150344223 |
LRSAM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS150344737 |
GAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Giant axonal neuropathy 1, GAN-related disorder |
| RS150345121 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS150346282 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, ABCD1-related disorder |
| RS150348015 |
CLN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3 |
| RS150348863 |
LINS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150349588 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS150351766 |
CYP7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
CYP7A1-related disorder, CYP7A1-related disorder |